Zydus Lifesciences Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

6,864.50

6,123.20

6,573.70

6,527.90

5,269.10

5,237.00

6,207.50

Other Operating Income

0.00

Total Operating income

6,864.50

6,123.20

6,573.70

6,527.90

5,269.10

5,237.00

6,207.50

Raw Material Cost

1,216.40

1,327.10

1,218.90

1,164.40

1,026.50

1,066.50

1,115.50

Purchase of Finished goods

851.50

589.10

658.20

572.60

571.10

483.90

522.40

(Increase) / Decrease In Stocks

-231.60

-225.70

-87.60

-39.90

-14.20

-79.00

-51.80

Employee Cost

1,139.70

1,034.20

1,005.20

971.40

946.50

879.20

883.50

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

2,072.10

1,382.70

1,690.50

1,733.90

1,351.60

1,425.00

1,653.90

Total Expenditure (Excl Depreciation)

5,048.10

4,107.40

4,485.20

4,402.40

3,881.50

3,775.60

4,123.50

Operating Profit (PBDIT) excl Other Income

1,816.40

2,015.80

2,088.50

2,125.50

1,387.60

1,461.40

2,084.00

Other Income

111.40

109.00

154.90

80.60

57.50

68.20

63.20

Operating Profit (PBDIT)

1,927.80

2,124.80

2,243.40

2,206.10

1,445.10

1,529.60

2,147.20

Interest

129.90

101.30

84.70

76.60

32.00

25.10

32.20

Exceptional Items

-84.90

-34.20

0.00

-219.60

-0.30

0.30

0.00

Gross Profit (PBDT)

1,713.00

1,989.30

2,158.70

1,909.90

1,413.10

1,504.50

2,115.00

Depreciation

359.60

301.90

238.10

237.90

229.00

233.60

215.30

Profit Before Tax

1,353.40

1,687.40

1,920.60

1,672.00

1,184.10

1,270.90

1,899.70

Tax

388.30

454.00

434.00

423.20

179.50

373.10

436.10

Provisions and contingencies

0.00

Profit After Tax

965.10

1,233.40

1,486.60

1,248.80

1,004.60

897.80

1,463.60

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

-0.30

0.30

0.00

Net Profit

965.10

1,233.40

1,486.60

1,248.80

1,004.30

898.10

1,463.60

Share in Profit of Associates

57.80

5.20

34.40

-5.10

21.90

22.10

18.90

Minority Interest

-19.20

-20.00

54.20

72.80

2.70

9.00

62.60

Other related items

0.00

Consolidated Net Profit

1,042.10

1,258.60

1,466.80

1,170.90

1,023.50

911.20

1,419.90

Equity Capital

100.60

Face Value

1.0

Reserves

0.00

Earnings per share (EPS)

10.36

12.51

14.58

11.64

10.17

9.06

14.11

Diluted Earnings per share

10.36

12.51

14.58

11.64

10.17

9.06

14.11

Operating Profit Margin (Excl OI)

26.79%

33.39%

32.29%

33.79%

27.08%

28.58%

34.47%

Gross Profit Margin

25.26%

32.95%

33.38%

30.36%

27.58%

29.42%

34.98%

PAT Margin

14.23%

20.43%

22.99%

19.85%

19.61%

17.56%

24.21%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2025 is 30.28% vs 16.96% in Dec 2024

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 1.82% vs 29.62% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 30.90% vs 25.87% in Dec 2024

Interest

YoY Growth in quarter ended Dec 2025 is 305.94% vs 61.62% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of Zydus Lifesci. With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

6,864.50

7,074.48

-209.98

-2.97%

Other Operating Income

0.00

Total Operating income

6,864.50

7,074.48

-209.98

-2.97%

Raw Material Cost

1,216.40

1,461.96

-245.56

-16.80%

Purchase of Finished goods

851.50

1,248.64

-397.14

-31.81%

(Increase) / Decrease In Stocks

-231.60

-78.52

-153.08

-194.96%

Employee Cost

1,139.70

1,324.98

-185.28

-13.98%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

2,072.10

1,862.36

209.74

11.26%

Total Expenditure (Excl Depreciation)

5,048.10

5,819.42

-771.32

-13.25%

Operating Profit (PBDIT) excl Other Income

1,816.40

1,255.06

561.34

44.73%

Other Income

111.40

206.34

-94.94

-46.01%

Operating Profit (PBDIT)

1,927.80

1,461.40

466.40

31.91%

Interest

129.90

14.03

115.87

825.87%

Exceptional Items

-84.90

-275.91

191.01

69.23%

Gross Profit (PBDT)

1,713.00

1,171.46

541.54

46.23%

Depreciation

359.60

278.35

81.25

29.19%

Profit Before Tax

1,353.40

893.11

460.29

51.54%

Tax

388.30

218.55

169.75

77.67%

Provisions and contingencies

0.00

Profit After Tax

965.10

674.56

290.54

43.07%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

965.10

674.56

290.54

43.07%

Share in Profit of Associates

57.80

-0.31

58.11

18,745.16%

Minority Interest

-19.20

-1.55

-17.65

-1,138.71%

Other related items

0.00

Consolidated Net Profit

1,042.10

675.80

366.30

54.20%

Equity Capital

100.60

161.55

-60.95

-37.73%

Face Value

1.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

10.36

8.37

1.99

23.78%

Diluted Earnings per share

10.36

8.36

2.00

23.92%

Operating Profit Margin (Excl OI)

26.79%

18.02%

0.00

8.77%

Gross Profit Margin

25.26%

16.82%

0.00

8.44%

PAT Margin

14.23%

9.69%

0.00

4.54%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 6,864.50 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 12.11% vs -6.85% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 30.28% vs 16.96% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 1,042.10 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -17.20% vs -14.19% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 1.82% vs 29.62% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 1,816.40 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -9.89% vs -3.48% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 30.90% vs 25.87% in Dec 2024

Quarterly - Interest

Interest 129.90 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 28.23% vs 19.60% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 305.94% vs 61.62% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 26.79%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024